All Stories

  1. Risk of amputations associated with SGLT2 inhibitors compared to DPP-4 inhibitors: A propensity-matched cohort study

    Article • Diabetes Obesity and Metabolism, August 2018, Wiley

    Gregory Calip

  2. Hydroxycarbamide adherence and cumulative dose associated with hospital readmission in sickle cell disease: a 6-year population-based cohort study

    Article • British Journal of Haematology, May 2018, Wiley

    Jifang Zhou, Gregory Calip

  3. Tumor necrosis factor-alpha inhibitors and risk of non-Hodgkin lymphoma in a cohort of adults with rheumatologic conditions

    Article • International Journal of Cancer, April 2018, Wiley

    Gregory Calip

  4. Characterization of opioid use in sickle cell disease

    Article • Pharmacoepidemiology and Drug Safety, August 2017, Wiley

    Jifang Zhou, Gregory Calip

  5. Erythropoiesis-stimulating agents in sickle cell anaemia

    Article • British Journal of Haematology, July 2017, Wiley

    Gregory Calip, Jifang Zhou